MedPath

Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction

Not Applicable
Completed
Conditions
Substance Dependence
Interventions
Behavioral: Cognitive Bias Modification
Registration Number
NCT03000699
Lead Sponsor
Centre for Addiction and Mental Health
Brief Summary

The purpose of this study is to determine whether computer bias modification for interpretation bias (CBM-I) is effective in the reduction of suicidal ideation in substance use disorders.

Detailed Description

Eighty-eight adult inpatients completing residential treatment in the Addictions Services at the Centre for Addiction and Mental Health (CAMH) will be randomized to receive CBM-I daily for one week, adjunct to the residential psychosocial treatment or to an assessment-only control condition. Participants will complete clinical measures consisting of interviews and questionnaires measuring suicidal ideation, hopelessness, depression, negative affect, and interpretation biases before, during and after treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Exhibit moderate suicide risk or greater
  • Be enrolled in the Addictions Services inpatient program
  • Fluent in reading English
  • Capacity to give informed consent
Exclusion Criteria
  • A lifetime diagnosis of a psychotic or bipolar disorder
  • Significant neurological disorder or psychical illness likely to interfere with participation
  • Psychotropic medication changes within the past two weeks

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Bias ModificationCognitive Bias Modification64 training paragraphs, approximately 10-20 seconds each, digitally recorded and presented stereophonically through headphones, delivered over the course of one week.
Primary Outcome Measures
NameTimeMethod
Columbia-Suicide Severity Rating Scale, Screen Version (C-SSRS)Seven days

This scale quantifies the severity of suicidal ideation and behaviour.

Secondary Outcome Measures
NameTimeMethod
Positive and Negative Affect Schedule (PANAS)Seven days

This questionnaire assesses current positive and negative mood

Beck Hopelessness Scale (BHS)Seven days

This questionnaire assesses thoughts and emotions associated with the future.

Beck Depression Inventory II (BDI-II)Seven days

This questionnaire assesses severity of depressive symptoms and cognitions.

Scrambled Sentences TestsSeven days

This computer test will be used as an implicit measure of negative interpretation bias.

Trial Locations

Locations (1)

Centre for Addiction and Mental Health

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath